A SBIR Phase I contract was awarded to Fibrogen, Inc. for $87,500.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Fibrogen, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Fibrogen, Inc. for $807,984.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Fibrogen, Inc. for $110,852.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Fibrogen, Inc. for $100,000.0 USD from the National Science Foundation.